# Avent, Inc. – FDA Inspection, Feb 21, 2020

Source: https://www.keypedia.com/records/fda_inspections/avent-inc/3f3dcf60-84c0-4d69-a334-9fd0019a8435
Source feed: FDA_Inspections

> FDA inspection 1118646 of Avent, Inc., February 21, 2020. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118646
- Company Name: Avent, Inc.
- Inspection Date: 2020-02-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1275741 - 2025-07-10
- FDA Inspection 1089505 - 2017-12-01
- FDA Inspection 1037129 - 2017-08-09
- [FDA Inspection 994354 - 2016-11-28](https://www.keypedia.com/records/fda_inspections/avent-inc/aa54d4b7-74b6-4346-aed5-368e03779c9f)
- [FDA Inspection 997411 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/avent-inc/be8fe316-2223-4c03-8112-adfb3400f61a)

Company: https://www.keypedia.com/companies/avent-inc/f7d3c6c2-23e3-480a-a54d-56949ec4b1da

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c